Octapharma chooses IDBS' E-WorkBook 10

Biopharmaceuticals organization Octapharma GmbH has chosen E-WorkBook 10 from IDBS, the company said.

The web-based electronic laboratory notebook (ELN) will be rolled out in Germany early this year to replace paper-based research and development (R&D) and protect valuable IP.

Users will be able to search for information in real time and follow a specific researcher or experiment as part of the application, to boost collaboration and productivity.

E-WorkBook 10 will service the breadth of expertise across Octapharma´s German labs, including High Throughput Screening (HTS), fermentation, analytics and formulations. Increasingly, it will also help the organization to collect and secure data from its biotech partnerships. The transition from legacy technology and Excel is already underway, supported by IDBS´ Munich team on the ground.

The web-based deployment of E-WorkBook 10 delivers Octapharma a small IT footprint throughout the organization – compared to an on-premise solution – and a mobile approach to R&D. Scientists can access data from anywhere in the world with just a connection to the internet and their internal system.

Headquartered in Lachen, Switzerland, Octapharma is a human protein product manufacturer, in business since 1983. Its core business is the development and production of human proteins from human plasma and human cell-lines.

Octapharma has 48 subsidiaries and representative offices and employs approximately 6,000 people worldwide to support the treatment of patients in over 100 countries with products across the therapeutic areas of Haematology (coagulation disorders), Immunotherapy (immune disorders) and Critical Care.

Octapharma owns five state-of-the-art production facilities in Austria, France, Germany, Sweden and Mexico.

IDBS is a leading global provider of advanced software for research and development (R&D) organizations to securely capture, manage, share and exploit structured and unstructured data.

Founded in 1989, IDBS is headquartered in the United Kingdom with offices across Europe, Asia and the United States.